Vaishnavi Herbals India Profile
Key Indicators
- Authorised Capital ₹ 23.00 Cr
as on 18-07-2024
- Paid Up Capital ₹ 22.99 Cr
as on 18-07-2024
- Company Age 9 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.30 M
as on 18-07-2024
- Revenue 11.57%
(FY 2022)
- Profit 24.05%
(FY 2022)
- Ebitda 46.67%
(FY 2022)
- Net Worth -31.36%
(FY 2022)
- Total Assets -3.73%
(FY 2022)
About Vaishnavi Herbals India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 23.00 Cr and a paid-up capital of Rs 22.99 Cr.
The company currently has active open charges totaling ₹6.30 M.
Shanthi Palanivelu and Sivasubramanian Kolandaivelu serve as directors at the Company.
- CIN/LLPIN
U74900TN2015PTC100430
- Company No.
100430
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 May 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vaishnavi Herbals India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shanthi Palanivelu  | Managing Director | 08-May-2015 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sivasubramanian Kolandaivelu | Director | 08-May-2015 | Current |
Financial Performance of Vaishnavi Herbals India.
Vaishnavi Herbals India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 11.57% increase. The company also saw a substantial improvement in profitability, with a 24.05% increase in profit. The company's net worth observed a substantial decline by a decrease of 31.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vaishnavi Herbals India?
In 2022, Vaishnavi Herbals India had a promoter holding of 83.36% and a public holding of 16.64%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shivanthi Agro Estates P LtdActive 28 years 11 monthsShanthi Palanivelu and Sivasubramanian Kolandaivelu are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Vijaya Bank Creation Date: 04 Nov 2016 | ₹6.30 M | Open |
How Many Employees Work at Vaishnavi Herbals India?
Unlock and access historical data on people associated with Vaishnavi Herbals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vaishnavi Herbals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vaishnavi Herbals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
